Knowing when a claim could benefit from a referral to field case management can be complicated. In this video, we have outlined key medical considerations that can guide your decision-making. If any of these factors apply to your claim, it may be time to make a referral. Our expert staff of case managers is here to help facilitate timely and appropriate medical care while coordinating a safe and timely return to work.
As we wrap up the year, we’d like to thank everyone who supported The Sounding Board blog in 2019. The official launch took place in July and since then we have shared 47 posts.
Automating claims workflows have long been a central strategy for Property & Casualty (P&C) claims organizations and collision repair facilities seeking to efficiently and accurately process claims and manage repair complexity. In today’s dynamic environment, where each week seems to bring a new technology advancement, staying up-to-date on the latest automation technologies is key to understanding the future of the P&C industry.
Many state formularies have implementation deadlines approaching in early 2020. Here's what you need to know.
We’re back with the second part of our exclusive interview with Peter Rousmaniere in which he discusses how current trends will impact the future of the industry and gives us a preview of what he plans to do next after his retirement from workers’ comp. Here’s part 2.
Mitchell's all-makes scan tools from Bosch offer full access to FCA secure vehicle networks and dramatic speed improvements for pre- and post-scanning.
In September 2019, the U.S. Food and Drug Administration (FDA) reported the discovery of low levels of an impurity in brand, generic, and over- the-counter (OTC) versions of a popular heartburn medication, Zantac® (Ranitidine HCl) 1, prompting a flurry of manufacturer recalls, national distribution halts, and product removals from retail pharmacy shelves. Ranitidine is an H2 (Histamine-2) blocker approved as a prescription medicine for treatment and prevention of GI ulcers and gastroesophageal reflux disease (GERD). OTC versions are approved for relief of acid indigestion and sour stomach. H2 blockers (like Tagamet, Pepcid, and Zantac) act by reducing the amount of acid produced by cells lining the stomach.